First Commonwealth Financial Corp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $420K | Sell |
17,457
-1,212
| -6% | -$31.7K | 0.06% | 211 |
|
|
2026
Q1 | $524K | Buy |
+18,669
| New | +$497K | 0.08% | 174 |
|
|
2024
Q4 | – | Sell |
-7,107
| Closed | -$206K | – | 228 |
|
|
2024
Q3 | $206K | Sell |
7,107
-338
| -5% | -$9.86K | 0.05% | 195 |
|
|
2024
Q2 | $208K | Sell |
7,445
-463
| -6% | -$12.7K | 0.05% | 192 |
|
|
2024
Q1 | $219K | Sell |
7,908
-219
| -3% | -$6.08K | 0.06% | 189 |
|
|
2023
Q4 | $234K | Sell |
8,127
-1,131
| -12% | -$34.2K | 0.07% | 158 |
|
|
2023
Q3 | $307K | Buy |
9,258
+488
| +6% | +$17.3K | 0.1% | 142 |
|
|
2023
Q2 | $322K | Sell |
8,770
-30
| -0.3% | -$1.17K | 0.1% | 138 |
|
|
2023
Q1 | $359K | Sell |
8,800
-50
| -0.6% | -$2.16K | 0.13% | 140 |
|
|
2022
Q4 | $453K | Sell |
8,850
-205
| -2% | -$9.83K | 0.17% | 125 |
|
|
2022
Q3 | $396K | Buy |
9,055
+205
| +2% | +$9.96K | 0.17% | 123 |
|
|
2022
Q2 | $464K | Sell |
8,850
-2,057
| -19% | -$105K | 0.17% | 116 |
|
|
2022
Q1 | $564K | Buy |
10,907
+2,087
| +24% | +$108K | 0.18% | 106 |
|
|
2021
Q4 | $521K | Sell |
8,820
-3
| -0% | -$149 | 0.17% | 109 |
|
|
2021
Q3 | $379K | Sell |
8,823
-86
| -1% | -$3.81K | 0.14% | 127 |
|
|
2021
Q2 | $349K | Buy |
8,909
+615
| +7% | +$23.9K | 0.12% | 140 |
|
|
2021
Q1 | $301K | Sell |
8,294
-45
| -0.5% | -$1.6K | 0.12% | 139 |
|
|
2020
Q4 | $307K | Sell |
8,339
-292
| -3% | -$10.7K | 0.13% | 133 |
|
|
2020
Q3 | $301K | Buy |
8,631
+1,475
| +21% | +$51.7K | 0.14% | 130 |
|
|
2020
Q2 | $222K | Sell |
7,156
-414
| -5% | -$14.1K | 0.1% | 154 |
|
|
2020
Q1 | $235K | Hold |
7,570
| – | – | 0.14% | 121 |
|
|
2019
Q4 | $281K | Hold |
7,570
| – | – | 0.15% | 113 |
|
|
2019
Q3 | $258K | Sell |
7,570
-464
| -6% | -$16.9K | 0.15% | 116 |
|
|
2019
Q2 | $330K | Sell |
8,034
-374
| -4% | -$14.9K | 0.2% | 96 |
|
|
2019
Q1 | $338K | Sell |
8,408
-2,585
| -24% | -$104K | 0.21% | 99 |
|
|
2018
Q4 | $455K | Buy |
10,993
+316
| +3% | +$13.1K | 0.32% | 81 |
|
|
2018
Q3 | $447K | Sell |
10,677
-747
| -7% | -$28.8K | 0.3% | 86 |
|
|
2018
Q2 | $393K | Buy |
11,424
+434
| +4% | +$14.8K | 0.4% | 81 |
|
|
2018
Q1 | $370K | Sell |
10,990
-900
| -8% | -$30.9K | 0.39% | 88 |
|
|
2017
Q4 | $408K | Buy |
11,890
+439
| +4% | +$15K | 0.43% | 72 |
|
|
2017
Q3 | $388K | Buy |
11,451
+485
| +4% | +$15.6K | 0.44% | 74 |
|
|
2017
Q2 | $350K | Buy |
10,966
+2,852
| +35% | +$89.9K | 0.39% | 86 |
|
|
2017
Q1 | $263K | Sell |
8,114
-654
| -7% | -$20.6K | 0.34% | 80 |
|
|
2016
Q4 | $271K | Hold |
8,768
| – | – | 0.34% | 80 |
|
|
2016
Q3 | $282K | Hold |
8,768
| – | – | 0.37% | 74 |
|
|
2016
Q2 | $293K | Sell |
8,768
-949
| -10% | -$30.3K | 0.37% | 73 |
|
|
2016
Q1 | $274K | Sell |
9,717
-239
| -2% | -$6.83K | 0.34% | 75 |
|
|
2015
Q4 | $304K | Sell |
9,956
-140
| -1% | -$4.4K | 0.36% | 75 |
|
|
2015
Q3 | $301K | Sell |
10,096
-498
| -5% | -$16K | 0.38% | 73 |
|
|
2015
Q2 | $337K | Sell |
10,594
-1,337
| -11% | -$43.6K | 0.39% | 73 |
|
|
2015
Q1 | $394K | Buy |
11,931
+2,254
| +23% | +$71.7K | 0.44% | 69 |
|
|
2014
Q4 | $286K | Sell |
9,677
-2,477
| -20% | -$71K | 0.31% | 81 |
|
|
2014
Q3 | $341K | Sell |
12,154
-252
| -2% | -$7.07K | 0.37% | 77 |
|
|
2014
Q2 | $350K | Sell |
12,406
-368
| -3% | -$10.5K | 0.37% | 78 |
|
|
2014
Q1 | $390K | Buy |
12,774
+158
| +1% | +$4.71K | 0.44% | 72 |
|
|
2013
Q4 | $367K | Buy |
12,616
+922
| +8% | +$26.8K | 0.41% | 75 |
|
|
2013
Q3 | $319K | Sell |
11,694
-211
| -2% | -$5.74K | 0.39% | 78 |
|
|
2013
Q2 | $316K | Buy |
+11,905
| New | +$329K | 0.4% | 72 |
|
Other funds holding PFE
First Commonwealth Financial Corp's PFE Position: Q2 2026 in Review
First Commonwealth Financial Corp reduced its Pfizer (PFE) stake by 6.5% in Q2 2026, selling an estimated $31.7K and leaving 17,457 shares worth $420K. The position accounts for 0.06% of the portfolio, ranked #211.
First Commonwealth Financial Corp first reported a position in PFE in Q2 2013 and has held it in 48 quarters since. The position peaked at $564K in Q1 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- First Commonwealth Financial Corp held 17,457 shares of Pfizer worth $420K as of Q2 2026.
- First Commonwealth Financial Corp sold 1,212 Pfizer shares in Q2 2026, an estimated $31.7K.
- Pfizer made up 0.06% of First Commonwealth Financial Corp's portfolio in Q2 2026, its #211 holding.
- First Commonwealth Financial Corp first reported a position in Pfizer in Q2 2013 and has held it in 48 quarters since.
- First Commonwealth Financial Corp's Pfizer position peaked at $564K in Q1 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on First Commonwealth Financial Corp's 13F filing for Q2 2026, filed 12 Aug 2026.